CIK: 2005407 - Address: C/O Forbion Capital Partners,, Gooimeer 2-35,, Naarden, P7 1411 DC
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

1/2/25 16:15
12/30/24
NAMSNewamsterdam Pharma Co N.V.P7HealthDrugPharmaceutical PreparationsForgrowth Nap B.V.P7TS-76225.540-30010,656I
12/30/24 16:15
12/26/24
NAMSNewamsterdam Pharma Co N.V.P7HealthDrugPharmaceutical PreparationsForgrowth Nap B.V.P7TS.m-1,94625.980-75-110,686I
12/26/24 16:15
12/20/24
NAMSNewamsterdam Pharma Co N.V.P7HealthDrugPharmaceutical PreparationsForgrowth Nap B.V.P7TS.m-2,33025.580-91-110,761I
12/20/24 16:25
12/18/24
NAMSNewamsterdam Pharma Co N.V.P7HealthDrugPharmaceutical PreparationsForgrowth Nap B.V.P7TS.m-4,06725.860-157-110,852I
12/18/24 16:15
12/16/24
NAMSNewamsterdam Pharma Co N.V.P7HealthDrugPharmaceutical PreparationsForgrowth Nap B.V.P7TS.m-2,99625.950-115-111,009I
12/16/24 16:15
12/12/24
NAMSNewamsterdam Pharma Co N.V.P7HealthDrugPharmaceutical PreparationsForgrowth Nap B.V.P7TS.m-4,86025.340-192-211,125I
12/12/24 16:15
12/10/24
NAMSNewamsterdam Pharma Co N.V.P7HealthDrugPharmaceutical PreparationsForgrowth Nap B.V.P7TS.m-11,74125.400-462-411,316I
11/19/24 16:15
11/15/24
NAMSNewamsterdam Pharma Co N.V.P7HealthDrugPharmaceutical PreparationsForgrowth Nap B.V.P7TS.m-1,04825.070-42011,779I
11/15/24 16:36
11/13/24
NAMSNewamsterdam Pharma Co N.V.P7HealthDrugPharmaceutical PreparationsForgrowth Nap B.V.P7TS.m-27325.010-11011,821I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact